Phagocytes transmit Chlamydia pneumoniae from the lungs to the vasculature

被引:82
作者
Gieffers, J
van Zandbergen, G
Rupp, J
Sayk, F
Krüger, S
Ehlers, S
Solbach, W
Maass, M
机构
[1] Univ Lubeck, Inst Med Microbiol & Hyg, D-23538 Lubeck, Germany
[2] Univ Lubeck, Inst Pathol, D-23538 Lubeck, Germany
[3] Res Ctr Borstel, Div Mol Infect Biol, Borstel, Germany
关键词
animal model; chlamydia; dissemination; macrophages; monocytes; vascular infection;
D O I
10.1183/09031936.04.00093304
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Chlamydia pneumoniae, a major cause of community-acquired pneumonia, primarily infects the respiratory tract. Chronic infection of nonrespiratory sites, such as the vascular wall, the brain or blood monocytes, requires evasion from the lungs and spreading via the bloodstream. The cell types involved in dissemination are insufficiently characterised. In this study, New Zealand White rabbits were infected intratracheally with C. pneumoniae, and lung manifestation and systemic dissemination were monitored by polymerase chain reaction and immunohistochemistry. Infection of the lungs was characterised by an early phase dominated by granulocytes and a late phase dominated by alveolar macrophages (AM). Granulocytes, AM and alveolar epithelial cells acted as host cells for chlamydiae, which remained detectable for up to 8 weeks. AM transported the pathogen to the peribronchiolar lymphatic tissue, and subsequently C. pneumoniae entered the spleen and the aorta via dissemination by peripheral blood monocytes. In conclusion, Chlamydia pneumoniae-infected alveolar macrophages; transmigrate through the mucosal barrier, and give the pathogen access to the lymphatic system and the systemic circulation. Infected peripheral blood monocytes are the vector system within the bloodstream and transmit the infection to the vascular wall. This is the first description of granulocytes acting as a reservoir for Chlamydia pneumoniae early in infection.
引用
收藏
页码:506 / 510
页数:5
相关论文
共 21 条
[1]   Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain [J].
Balin, BJ ;
Gerard, HC ;
Arking, EJ ;
Appelt, DM ;
Branigan, PJ ;
Abrams, JT ;
Whittum-Hudson, JA ;
Hudson, AP .
MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 1998, 187 (01) :23-42
[2]   High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors [J].
Boman, J ;
Söderberg, S ;
Forsberg, J ;
Birgander, LS ;
Allard, A ;
Persson, K ;
Jidell, E ;
Kumlin, U ;
Juto, P ;
Waldenström, A ;
Wadell, G .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (01) :274-277
[3]   Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis [J].
Davidson, M ;
Kuo, CC ;
Middaugh, JP ;
Campbell, LA ;
Wang, SP ;
Newman, WP ;
Finley, JC ;
Grayston, JT .
CIRCULATION, 1998, 98 (07) :628-633
[4]   Standardizing Chlamydia pneumoniae assays:: Recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada) [J].
Dowell, SF ;
Peeling, RW ;
Boman, J ;
Carlone, GM ;
Fields, BS ;
Guarner, J ;
Hammerschlag, MR ;
Jackson, LA ;
Kuo, CC ;
Maass, M ;
Messmer, TO ;
Talkington, DF ;
Tondella, ML ;
Zaki, SR ;
Bandea, C ;
Black, C ;
O'Conner, S ;
Papp, J ;
Perilla, MJ ;
Schuchat, A ;
Stevens, V ;
Van Beneden, CA ;
Zell, ER ;
Cohen, C ;
Campbell, LA ;
Wwang, SP ;
Grayston, JT ;
Deal, CD ;
Gaydos, C ;
Schindler, L ;
Taylor, CE ;
Mahony, J ;
Fong, IW ;
Leinonen, M ;
Saikku, P ;
Maas, M ;
Ossewaarde, JM ;
Persson, K ;
Boman, J ;
Apfalter, P .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (04) :492-502
[5]   Rabbit model for Chlamydia pneumoniae infection [J].
Fong, IW ;
Chiu, B ;
Viira, E ;
Fong, MW ;
Jang, D ;
Mahony, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (01) :48-52
[6]   Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells [J].
Gaydos, CA ;
Summersgill, JT ;
Sahney, NN ;
Ramirez, JA ;
Quinn, TC .
INFECTION AND IMMUNITY, 1996, 64 (05) :1614-1620
[7]   Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis [J].
Gieffers, J ;
Pohl, D ;
Treib, J ;
Dittmann, R ;
Stephan, C ;
Klotz, K ;
Hanefeld, F ;
Solbach, W ;
Haass, A ;
Maass, M .
ANNALS OF NEUROLOGY, 2001, 49 (05) :585-589
[8]  
Gieffers J, 2001, CIRCULATION, V103, P351
[9]   The role of Chlamydia pneumoniae in atherosclerosis -: Editorial response [J].
Grayston, JT ;
Campbell, LA .
CLINICAL INFECTIOUS DISEASES, 1999, 28 (05) :993-994
[10]   INFECTIONS CAUSED BY CHLAMYDIA-PNEUMONIAE STRAIN TWAR [J].
GRAYSTON, JT .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (05) :757-763